DEFINING CRITERIA to DECLARE ELIMINATION of LEPROSY Report of an Informal Consultation

Total Page:16

File Type:pdf, Size:1020Kb

DEFINING CRITERIA to DECLARE ELIMINATION of LEPROSY Report of an Informal Consultation DEFINING CRITERIA TO DECLARE ELIMINATION OF LEPROSY Report of an informal consultation Mexico City, Mexico, 10-12 February 2020 1 Defining criteria to declare elimination of leprosy: Report of an informal consultation meeting, Mexico City, Mexico, 10-12 February 2020 ISBN 978-92-9022-833-2 © World Health Organization 2020 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial- ShareAlike 3.0 IGO license (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this license, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons license. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the license shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. Leprosy: Global consultation of National Leprosy Programme managers, partners and affected persons on Global Leprosy Strategy 2021–2030: Report of the virtual meeting 26-30 October 2020. New Delhi: World Health Organization, Regional Office for South-East Asia; 2017. License: CC BY-NCSA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris. Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for commercial use and queries on rights and licensing, see http://www.who.int/about/licensing. Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely with the user. General disclaimers. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’ products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters. All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use. Printed in India. 2 Contents Abbreviations .......................................................................................................................................... 4 1. Inaugural session .....................................................................................................................................5 1.1. Introductory messages ........................................................................................................... 5 1.2. Statement by partners ............................................................................................................ 5 1.3. Introduction of participants.................................................................................................... 6 1.4. Objectives and expected outcomes ....................................................................................... 6 2. Overview of leprosy control .................................................................................................................7 2.1. Current global leprosy situation ............................................................................................. 7 2.2. History of leprosy control ....................................................................................................... 8 3. Elimination of leprosy as a public health problem ......................................................................8 3.1. Generic framework for control, elimination and eradication of NTDs ................................... 8 3.2. World Health Assembly resolutions, definition of leprosy as a public health problem and global progress .............................................................................................................. 10 3.3. From control to elimination as a public health problem: experience from Mexico ............ 11 3.4. Validation of elimination as a public health problem: example of other diseases .............. 12 3.5. Validation of elimination of leprosy as a public health problem: outcome of a consultation in the Region of the Americas ......................................................................... 13 3.6. Group work: elimination of leprosy as a public health problem .......................................... 14 4. From elimination as a public health problem to interruption of transmission ............. 15 4.1. NTD Roadmap 2021‒2030 .................................................................................................... 15 4.2. Leprosy profile in NTD Roadmap 2021‒2030 and post-2020 Global Leprosy Strategy ....... 15 4.3. Conceptual framework: interruption of transmission and elimination of disease .............. 17 4.4. Possible strategies to achieve interruption of transmission ................................................ 17 4.5. Defining interruption of transmission retro-actively............................................................ 20 4.6. Modelling to predict future trends ....................................................................................... 21 4.7. Elimination criteria for other diseases.................................................................................. 21 4.8. Verification of elimination for other diseases – “Elimination dossier” ................................ 21 4.9. Further research needs ........................................................................................................ 23 5. Other business ........................................................................................................................................ 24 5.1. Lucio phenomenon ............................................................................................................... 24 5.2. Global Partnership for Zero Leprosy .................................................................................... 24 6. Conclusions and recommendations ............................................................................................... 25 7. References ............................................................................................................................................... 26 Annex 1: List of participants ..................................................................................................................... 28 Annex 2: Programme................................................................................................................................... 30 3 Abbreviations BCG bacille Calmette-Guérin G2D grade-2 disability GPZL Global Partnership for Zero Leprosy HAT human African trypanosomiasis ILEP International Federation of Anti-Leprosy Associations LEM leprosy elimination monitoring MB multi-bacillary MDA mass drug administration MDT multidrug therapy MIP Mycobacterium indicum pranii NTD neglected tropical disease PAHO Pan-American Health Organization PEP post-exposure prophylaxis SDG sustainable development goal SHF Sasakawa Health Foundation TAS transmission assessment survey TT trachomatous trichiasis WHA World Health Assembly WHO World Health Organization 4 1. Inaugural session 1.1. Introductory messages Mr Cristian Morales, Pan-American Health Organization (PAHO)/World Health Organization (WHO) Representative to Mexico formally opened the Informal consultation on defining criteria to declare elimination of leprosy. On behalf of the host country, Dr Ruy López-Ridaura, Director-General of the Disease Control and Prevention Centre, Ministry of Health, welcomed all participants to Mexico. In his opening remarks he highlighted the achievements of Mexico’s leprosy control programme. Leprosy was once a very prevalent disease, but new cases have become rather rare and are increasingly confined to fewer geographic areas. 1.2. Statement by partners Ms Arielle Cavaliero, Global Franchise Lead (Leprosy) of Novartis International AG, reiterated the long-time commitment of Novartis, donating medicines for multidrug therapy (MDT) since 2001. She
Recommended publications
  • Medicinal Practices of Sacred Natural Sites: a Socio-Religious Approach for Successful Implementation of Primary
    Medicinal practices of sacred natural sites: a socio-religious approach for successful implementation of primary healthcare services Rajasri Ray and Avik Ray Review Correspondence Abstract Rajasri Ray*, Avik Ray Centre for studies in Ethnobiology, Biodiversity and Background: Sacred groves are model systems that Sustainability (CEiBa), Malda - 732103, West have the potential to contribute to rural healthcare Bengal, India owing to their medicinal floral diversity and strong social acceptance. *Corresponding Author: Rajasri Ray; [email protected] Methods: We examined this idea employing ethnomedicinal plants and their application Ethnobotany Research & Applications documented from sacred groves across India. A total 20:34 (2020) of 65 published documents were shortlisted for the Key words: AYUSH; Ethnomedicine; Medicinal plant; preparation of database and statistical analysis. Sacred grove; Spatial fidelity; Tropical diseases Standard ethnobotanical indices and mapping were used to capture the current trend. Background Results: A total of 1247 species from 152 families Human-nature interaction has been long entwined in has been documented for use against eighteen the history of humanity. Apart from deriving natural categories of diseases common in tropical and sub- resources, humans have a deep rooted tradition of tropical landscapes. Though the reported species venerating nature which is extensively observed are clustered around a few widely distributed across continents (Verschuuren 2010). The tradition families, 71% of them are uniquely represented from has attracted attention of researchers and policy- any single biogeographic region. The use of multiple makers for its impact on local ecological and socio- species in treating an ailment, high use value of the economic dynamics. Ethnomedicine that emanated popular plants, and cross-community similarity in from this tradition, deals health issues with nature- disease treatment reflects rich community wisdom to derived resources.
    [Show full text]
  • TFG QU Gonzalez Fernandez, Nuria.Pdf
    Tutor/s Dra. Elisabet Fuguet Jordà Departament d’Enginyeria Química i Química Analítica Dr. Fermin Huarte Larrañaga Departament de Ciència dels Materials i Química Física Treball Final de Grau Gender perspective in the subjects of the Chemistry Degree of the University of Barcelona: contribution of women to the curriculum of the Degree. Perspectiva de gènere en les assignatures del Grau de Química de la Universitat de Barcelona: contribucions de científiques en els continguts del Grau. Núria González Fernández June 2021 Aquesta obra està subjecta a la llicència de: Reconeixement–NoComercial-SenseObraDerivada http://creativecommons.org/licenses/by-nc-nd/3.0/es/ Courage is like a habit, a virtue: you get it by courageous acts. It’s like you learn to swim by swimming. You learn courage by couraging. Marie Maynard Daly Vull agrair a tots els docents que, al llarg de la carrera, m’han fet sentir part de la ciència i han col·laborat al desenvolupament del meu sentit de la curiositat. M’han format com a professional però també com a persona amb esperit crític. En especial a la meva tutora Elisabet i al meu tutor Fermin, que m’han fet creure en aquest treball i en la importància del mateix, gràcies per oferir la possibilitat d’acabar el grau de la manera més satisfactòria. També a la meva família, que m’ha acompanyat durant tots els anys de formació i especialment ara. Finalment dedicar aquest treball en definitiva a totes les dones que m’envolten, amigues, professores, àvies i mare, gràcies per ser referents. REPORT Gender perspective in the subjects of the Chemistry Degree… 1 CONTENTS 1.
    [Show full text]
  • Dictionary of Cultivated Plants and Their Regions of Diversity Second Edition Revised Of: A.C
    Dictionary of cultivated plants and their regions of diversity Second edition revised of: A.C. Zeven and P.M. Zhukovsky, 1975, Dictionary of cultivated plants and their centres of diversity 'N -'\:K 1~ Li Dictionary of cultivated plants and their regions of diversity Excluding most ornamentals, forest trees and lower plants A.C. Zeven andJ.M.J, de Wet K pudoc Centre for Agricultural Publishing and Documentation Wageningen - 1982 ~T—^/-/- /+<>?- •/ CIP-GEGEVENS Zeven, A.C. Dictionary ofcultivate d plants andthei rregion so f diversity: excluding mostornamentals ,fores t treesan d lowerplant s/ A.C .Zeve n andJ.M.J ,d eWet .- Wageninge n : Pudoc. -11 1 Herz,uitg . van:Dictionar y of cultivatedplant s andthei r centreso fdiversit y /A.C .Zeve n andP.M . Zhukovsky, 1975.- Me t index,lit .opg . ISBN 90-220-0785-5 SISO63 2UD C63 3 Trefw.:plantenteelt . ISBN 90-220-0785-5 ©Centre forAgricultura l Publishing and Documentation, Wageningen,1982 . Nopar t of thisboo k mayb e reproduced andpublishe d in any form,b y print, photoprint,microfil m or any othermean swithou t written permission from thepublisher . Contents Preface 7 History of thewor k 8 Origins of agriculture anddomesticatio n ofplant s Cradles of agriculture and regions of diversity 21 1 Chinese-Japanese Region 32 2 Indochinese-IndonesianRegio n 48 3 Australian Region 65 4 Hindustani Region 70 5 Central AsianRegio n 81 6 NearEaster n Region 87 7 Mediterranean Region 103 8 African Region 121 9 European-Siberian Region 148 10 South American Region 164 11 CentralAmerica n andMexica n Region 185 12 NorthAmerica n Region 199 Specieswithou t an identified region 207 References 209 Indexo fbotanica l names 228 Preface The aimo f thiswor k ist ogiv e thereade r quick reference toth e regionso f diversity ofcultivate d plants.Fo r important crops,region so fdiversit y of related wild species areals opresented .Wil d species areofte nusefu l sources of genes to improve thevalu eo fcrops .
    [Show full text]
  • Developmental Studies on Novel Biodegradable Polyester Films from Maravetti Oil
    J. Environ. Nanotechnol. Volume 8, No. 4 pp. 01-07 ISSN (Print): 2279-0748 ISSN (Online): 2319-5541 doi:10.13074/jent.2019.12.194379 Developmental Studies on Novel Biodegradable Polyester Films from Maravetti Oil T. Sahaya Maria Jeyaseeli1, I. Antony Danish2, J. Shakina1* 1Department of Chemistry, Sarah Tucker College (Autonomous), Tirunelveli, TN, India. 2Department of Chemistry, Sadakathullah Appa College (Autonomous), Tirunelveli, TN, India. Abstract Novel biodegradable polyester film was synthesised from naturally available Maravetti oil, formic acid and 30% hydrogen peroxide by stepwise polymerisation technique. The polymer was prepared by resin react with styrene. The UV, FTIR and NMR spectral studies carried out to identify the nature of the polymer formed. SEM analysis confirmed that the polymer was biodegradable in nature. The biodegradability of the polyester film was studied by soil burial test. The thermal degradation at different time intervals were analysed by TG-DTA analysis. The cross- linking ability of the polymers was checked by DSC analysis. Mechanical properties like tensile strength and impact strength were characterized. The resulted polymers have satisfied mechanical performance and fast curing speed. Keywords: Cross-linking; Degradation; Polymer Soil Burial; Styrene. 1. INTRODUCTION peroxide (30%) (Rankem) were used in the first step functionalization. Maleic acid (Rankem) and In our world over 6.3 billion plastics are Morpholine (Rankem). Benzoyl peroxide (Rankem) generated, only 9% is recycled, 12% incinerated, 79% was used as a radical initiator and N, N-Dimethyl accumulated in natural environment. In the production aniline (Rankem) was used as accelerator in the curing of plastics, monomers used which are derived from process.
    [Show full text]
  • India Report On
    AG:GCP/RAS/186/JPN Field Document No.2006/03 FAO/GOVERNMENT COOPERATIVE PROGRAM Report on the Establishment of the National Information Sharing Mechanism on the Implementation of the Global Plan of Action for the Conservation and Sustainable Utilization of Plant Genetic Resources for Food and Agriculture in India Compiled by R.C. Agrawal Pratibha Brahmi Sanjeev Saxena Gurinder Jit Randhawa Kavita Gupta D.S. Mishra J.L. Karihaloo 2006 DEPARTMENT OF AGRICULTURE AND COOPERATION Ministry of Agriculture, Krishi Bhawan New Delhi-110 001, INDIA and NATIONAL BUREAU OF PLANT GENETIC RESOURCES (Indian Council of Agricultural Research) Pusa Campus, New Delhi-110 012, INDIA The designation and presentation of material in this publication do not imply the expression of any opinion whatsoever on the part of the Food and Agriculture Organization of the United Nations and National Bureau of Plant Genetic Resources/ Indian Council of Agricultural Research/Department of Agriculture and Co-operation concerning the legal status of any country, territory, city or area of its authorities or concerning the delimitation of its frontiers and boundaries. Published by: Director National Bureau of Plant Genetic Resources Pusa Campus, New Delhi - 110 012, India (on behalf of Department of Agriculture and Cooperation, Ministry of Agriculture, Government of India) Citation: Agrawal R.C., Brahmi Pratibha, Saxena Sanjeev, Randhawa Gurinder Jit, Gupta Kavita, Mishra D.S and Karihaloo J.L. (2006). Report on Establishment of the National Information Sharing Mechanism on the Implementation of the Global Plan of Action for the Conservation and Sustainable Utilization of Plant Genetic Resources for Food and Agriculture in India.
    [Show full text]
  • Intoduction to Ethnobotany
    Intoduction to Ethnobotany The diversity of plants and plant uses Draft, version November 22, 2018 Shipunov, Alexey (compiler). Introduction to Ethnobotany. The diversity of plant uses. November 22, 2018 version (draft). 358 pp. At the moment, this is based largely on P. Zhukovskij’s “Cultivated plants and their wild relatives” (1950, 1961), and A.C.Zeven & J.M.J. de Wet “Dictionary of cultivated plants and their regions of diversity” (1982). Title page image: Mandragora officinarum (Solanaceae), “female” mandrake, from “Hortus sanitatis” (1491). This work is dedicated to public domain. Contents Cultivated plants and their wild relatives 4 Dictionary of cultivated plants and their regions of diversity 92 Cultivated plants and their wild relatives 4 5 CEREALS AND OTHER STARCH PLANTS Wheat It is pointed out that the wild species of Triticum and rela­ted genera are found in arid areas; the greatest concentration of them is in the Soviet republics of Georgia and Armenia and these are regarded as their centre of origin. A table is given show- ing the geographical distribution of 20 species of Triticum, 3 diploid, 10 tetraploid and 7 hexaploid, six of the species are endemic in Georgia and Armenia: the diploid T. urarthu, the tetraploids T. timopheevi, T. palaeo-colchicum, T. chaldicum and T. carthlicum and the hexaploid T. macha, Transcaucasia is also considered to be the place of origin of T. vulgare. The 20 species are described in turn; they comprise 4 wild species, T. aegilopoides, T. urarthu (2n = 14), T. dicoccoides and T. chaldicum (2n = 28) and 16 cultivated species. A number of synonyms are indicated for most of the species.
    [Show full text]
  • The Military and Hospitaller Order of Saint Lazarus of Jerusalem
    The Military and Hospitaller Order of Saint Lazarus of Jerusalem INTERNATIONAL HOSPITALLER REPORT 2014 Thanks to: All contributors to charity and hospitaller activities Hospitaller Working Group PRC Committee Jurisdictions, Grand and Hereditary Commanderies Vice Grand Chancellor Administration Grand Commander The Military and Hospitaller Order of Saint Lazarus of Jerusalem 2 of 70 International Hospitaller Report 2014 Table of Contents Page 1. Table of Contents 2 2. Jurisdictions of the Order 3 3. Address by the Grand Master 5 4. Address by the Grand Commander 6 5. Introduction by the Grand Hospitaller 7 6. Foreword 8 7. General Overview 10 8. Leprosy and Tuberculosis 11 8.1 Leprosy History 11 8.1.2 Why is leprosy called Hansen’s disease 12 8.1.3 Leprosy today 12 8.1.4 Europe’s last Leper Colony 13 8.1.5 Leprosy is a great lady 14 8.1.6 Key facts of Leprosy (WHO) 15 8.1.7 Multidrug therapy 15 8.2 Tuberculosis 16 8.2.1 Mycobacterium-leprae and Mycobacterium-tuberculosis 17 8.2.2 Tuberculosis in our modern Society 17 9. Contribution of our Order in the Battle against Leprosy 18 10. Hospice and Palliative Care 26 11. Contribution of our Order in the field of Hospice and Palliative Care 28 11.1 One of the projects “the Saint Louis Hospital in Jerusalem” 34 12. Care for Children 36 13. Support of Handicapped People 49 14. Food Campaigns 51 15. Organ Transplants 53 16. Community Service 55 17. Miscellaneous, not classified 67 18. Atavis et Armis 70 International Hospitaller Report 2014 final – rectification 2016 02 03 2 of 70 The Military and Hospitaller Order of Saint Lazarus of Jerusalem 3 of 70 International Hospitaller Report 2014 2.
    [Show full text]
  • Phytosociological Studies of the Sacred Grove of Kanyakumari District, Tamilnadu, India
    ISSN (E): 2349 – 1183 ISSN (P): 2349 – 9265 5(1): 29–40, 2018 DOI: 10.22271/tpr.201 8.v5.i1 .006 Research article Phytosociological studies of the sacred grove of Kanyakumari district, Tamilnadu, India S. Sukumaran1*, A. Pepsi1, D. S. SivaPradesh1 and S. Jeeva2 1Department of Botany and Research centre, Nesamony Memorial Christian College, Marthandam, Kanyakumari-629165, Tamilnadu, India 2Department of Botany and Research centre, Scott Christian College, Nagercoil, Kanyakumari-629003, Tamilnadu, India *Corresponding Author: [email protected] [Accepted: 28 March 2018] Abstract: Sacred groves are forest patches conserved by the local people through religious and cultural practices. These groves are important reservoirs of biodiversity, preserving indigenous plant species and serving as asylum of Rare, Endangered and Threatened (RET) species. The present study was carried out in Muppuram coastal sacred grove of Kanyakumari district to reveal the plant diversity, structure and regeneration pattern of trees using quadrate method. About 102 plant species were recorded from the total area (0.2 ha) of the grove studied. The vegetation of the grove clearly indicates tropical dry evergreen forest. Malvaceae was the dominant family. Young plant species were dominating than older ones (> 160 cm). To avoid the rapid environmental degradation of the sacred grove, conserving the groves is urgent and it is necessary to conduct more researches on this grove as well as other groves of the district. Keywords: Floristic diversity - Regeneration - Conservation - Sacred groves - Traditional. [Cite as: Sukumaran S, Pepsi A, SivaPradesh DS & Jeeva S (2018) Phytosociological studies of the sacred grove of Kanyakumari district, Tamilnadu, India. Tropical Plant Research 5(1): 29–40] INTRODUCTION The degradation of tropical forests and destruction of habitat due to anthropogenic activities are the major causes of the decline in global biodiversity (Sukumaran et al.
    [Show full text]
  • Larval Host Plants of the Butterflies of the Western Ghats, India
    OPEN ACCESS The Journal of Threatened Taxa is dedicated to building evidence for conservaton globally by publishing peer-reviewed artcles online every month at a reasonably rapid rate at www.threatenedtaxa.org. All artcles published in JoTT are registered under Creatve Commons Atributon 4.0 Internatonal License unless otherwise mentoned. JoTT allows unrestricted use of artcles in any medium, reproducton, and distributon by providing adequate credit to the authors and the source of publicaton. Journal of Threatened Taxa Building evidence for conservaton globally www.threatenedtaxa.org ISSN 0974-7907 (Online) | ISSN 0974-7893 (Print) Monograph Larval host plants of the butterflies of the Western Ghats, India Ravikanthachari Nitn, V.C. Balakrishnan, Paresh V. Churi, S. Kalesh, Satya Prakash & Krushnamegh Kunte 10 April 2018 | Vol. 10 | No. 4 | Pages: 11495–11550 10.11609/jot.3104.10.4.11495-11550 For Focus, Scope, Aims, Policies and Guidelines visit htp://threatenedtaxa.org/index.php/JoTT/about/editorialPolicies#custom-0 For Artcle Submission Guidelines visit htp://threatenedtaxa.org/index.php/JoTT/about/submissions#onlineSubmissions For Policies against Scientfc Misconduct visit htp://threatenedtaxa.org/index.php/JoTT/about/editorialPolicies#custom-2 For reprints contact <[email protected]> Threatened Taxa Journal of Threatened Taxa | www.threatenedtaxa.org | 10 April 2018 | 10(4): 11495–11550 Larval host plants of the butterflies of the Western Ghats, Monograph India Ravikanthachari Nitn 1, V.C. Balakrishnan 2, Paresh V. Churi 3,
    [Show full text]
  • That the Tout Untuk Ta on Mi Lova U It Aliana
    THATTHE TOUT UNTUK TAUS ON20170348276A1 MI LOVAU IT ALIANA (19 ) United States (12 ) Patent Application Publication ( 10) Pub . No. : US 2017/ 0348276 A1 Bryson et al . (43 ) Pub . Date : Dec . 7 , 2017 ( 54 ) NASAL CANNABIDIOL COMPOSITIONS A61K 47 /26 (2006 .01 ) A61K 47 / 02 (2006 .01 ) (71 ) Applicant: Acerus Pharmaceutical Corporation , A61K 36 / 185 ( 2006 .01 ) Mississauga (CA ) A61K 31 /05 ( 2006 .01 ) A61K 9 / 06 ( 2006 . 01 ) (72 ) Inventors : Nathan Bryson , Toronto (CA ) ; A61K 47 / 44 ( 2006 . 01) Avinash Chander Sharma, Brampton A61K 9 /00 (2006 . 01) (CA ) (52 ) U . S . CI. CPC .. .. .. A61K 31/ 352 (2013 . 01 ) ; A61K 47 /44 (21 ) Appl . No. : 15 /613 , 116 (2013 .01 ) ; A61K 47/ 38 ( 2013 .01 ) ; A61K 47/ 26 (2013 .01 ) ; A61K 9 / 0043 ( 2013 . 01 ) ; A61K ( 22 ) Filed : Jun . 2 , 2017 36 / 185 ( 2013 .01 ) ; A61K 31 /05 ( 2013 . 01 ) ; Related U . S . Application Data A61K 9 /06 (2013 . 01 ) ; A61K 47/ 02 (2013 . 01) (60 ) Provisional application No . 62 /426 ,403 , filed on Nov. (57 ) ABSTRACT 25 , 2016 , provisional application No. 62 /344 ,486 , A nasally administered cannabinoid semi- solid or viscous filed on Jun . 2 , 2016 . liquid composition ; nasal methods for administering the nasal pharmaceutical compositions ; methods for manufac Publication Classification turing the nasal pharmaceutical compositions ; and nasal ( 51 ) Int. Cl. methods of treating diseases treatable by the nasal pharma A61K 31/ 352 ( 2006 .01 ) ceutical compositions formulated with a cannabinoid or A61K 4738 ( 2006 .01 ) mixtures thereof. MULTIT - 134 . - . - - - - - - - - 130 - 102 132 c 100 me 144 N 128 140 - 150 120 - 124 Patent Application Publication Dec. 7 , 2017 Sheet 1 of 9 US 2017 / 0348276 A1 ? ??? ? .
    [Show full text]
  • Research Journal of Pharmaceutical, Biological and Chemical Sciences
    ISSN: 0975-8585 Research Journal of Pharmaceutical, Biological and Chemical Sciences In-silico Analysis, Homology Modelling And Docking Studies Of Essential Proteins Of Mycobacterium Leprae For Effective Treatment Of Leprosy. Sesha Charan Pasupuleti*. Amity Institute of Biotechnology, Amity University, Noida, Uttar Pradesh, India. ABSTRACT The high emergence of multi-drug resistant strains of bacteria like Mycobacterium leprae caused the existing drugs to be ineffective against them. This impacted a need to quest novel targets and drug compounds to treat diseases like leprosy. Protein sequences of M.Leprae which are non-homologous to humans, participate in essential metabolic pathways of the bacteria and are necessary for the pathogen to survive were taken for study. Physiochemical characterisation, structural and functional analysis were carried out on these proteins. Their 3D structures were predicted were evaluated using various servers and workspaces. It was found that the proteins under study are acidic, thermostable and cytoplasmic in nature. Docking studies revealed that the herbal compounds which have least or no side effects were much more efficient than the chemical drugs. LysR family transcriptional regulator and MurE proteins of M.leprae were found to be the best targets to make novel drug formulations against the bacteria. Hops extract from Humuluslupulus, and Daucosterol from Justiciaadhatoda have maximum binding energies with the proteins under study. Thus the study showed that the herbal compounds interacted better with the proteins than the market drugs and were subjected to experimental evaluation to test their efficiency to treat leprosy. Keywords: Homology modelling, Molecular Docking, Leprosy, Mycobacterium Leprae, Herbal compounds, Drug discovery. *Corresponding author July–August 2018 RJPBCS 9(4) Page No.
    [Show full text]
  • WO 2017/208072 A2 07 December 2017 (07.12.2017) W ! P O PCT
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2017/208072 A2 07 December 2017 (07.12.2017) W ! P O PCT (51) International Patent Classification: (81) Designated States (unless otherwise indicated, for every A61K 31/05 (2006.01) kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, (21) International Application Number: CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, PCT/IB2017/000759 DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, (22) International Filing Date: HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KH, KN, KP, KR, 02 June 2017 (02.06.2017) KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, (25) Filing Language: English PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, (26) Publication Language: English SD, SE, SG, SK, SL, SM, ST, SV, SY,TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (30) Priority Data: 62/344,486 02 June 2016 (02.06.2016) US (84) Designated States (unless otherwise indicated, for every 62/426,403 25 November 2016 (25. 11.2016) US kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, (71) Applicant: ACERUS PHARMACEUTICAL CORPO¬ UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, RATION [CA/CA]; 2486 Dunwin Drive, Mississauga, On TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, tario L5L 1J9 (CA).
    [Show full text]